PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Willow Biosciences Inc. (WLLW.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA97111B4047

CUSIP

97111B404

Sector

Healthcare

Highlights

Market Cap

CA$3.61M

EPS (TTM)

-CA$0.05

Total Revenue (TTM)

CA$2.78M

Gross Profit (TTM)

CA$372.00K

EBITDA (TTM)

-CA$3.20M

Year Range

CA$0.02 - CA$0.15

Target Price

CA$2.00

Short %

0.07%

Short Ratio

0.09

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in Willow Biosciences Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-70.59%
15.56%
WLLW.TO (Willow Biosciences Inc.)
Benchmark (^GSPC)

Returns By Period

Willow Biosciences Inc. had a return of -61.54% year-to-date (YTD) and -80.77% in the last 12 months.


WLLW.TO

YTD

-61.54%

1M

-64.29%

6M

-70.59%

1Y

-80.77%

5Y*

-48.84%

10Y*

N/A

^GSPC (Benchmark)

YTD

2.90%

1M

3.70%

6M

10.94%

1Y

22.18%

5Y*

12.41%

10Y*

11.21%

*Annualized

Monthly Returns

The table below presents the monthly returns of WLLW.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-61.54%-61.54%
2024-5.00%21.05%-13.04%-5.00%36.84%-15.38%-13.64%5.26%5.00%-14.29%-5.56%-23.53%-35.00%
20238.70%-12.00%-18.18%44.44%-7.69%-4.17%-4.35%-27.27%6.25%-5.88%-12.50%42.86%-13.04%
2022-12.22%-8.86%-2.78%-28.57%-16.00%-19.05%-20.59%-11.11%0.00%-0.00%-4.17%-0.00%-74.44%
202121.37%14.08%-9.88%0.68%-15.65%-18.55%-12.87%-26.14%-15.38%-7.27%-14.71%3.45%-61.54%
202015.62%-16.22%-22.58%-10.42%-2.33%30.95%5.45%36.21%-6.33%-27.03%-1.85%120.75%82.81%
201933.33%-8.33%54.55%-5.88%2,262.50%-39.68%-34.21%-5.33%-1.41%2.86%-12.50%1.59%1,322.22%
2018-9.09%-10.00%-18.18%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of WLLW.TO is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of WLLW.TO is 77
Overall Rank
The Sharpe Ratio Rank of WLLW.TO is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of WLLW.TO is 99
Sortino Ratio Rank
The Omega Ratio Rank of WLLW.TO is 88
Omega Ratio Rank
The Calmar Ratio Rank of WLLW.TO is 44
Calmar Ratio Rank
The Martin Ratio Rank of WLLW.TO is 00
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Willow Biosciences Inc. (WLLW.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for WLLW.TO, currently valued at -0.71, compared to the broader market-2.000.002.004.00-0.711.59
The chart of Sortino ratio for WLLW.TO, currently valued at -1.08, compared to the broader market-6.00-4.00-2.000.002.004.00-1.082.16
The chart of Omega ratio for WLLW.TO, currently valued at 0.84, compared to the broader market0.501.001.502.000.841.29
The chart of Calmar ratio for WLLW.TO, currently valued at -0.82, compared to the broader market0.002.004.006.00-0.822.40
The chart of Martin ratio for WLLW.TO, currently valued at -2.15, compared to the broader market0.0010.0020.0030.00-2.159.79
WLLW.TO
^GSPC

The current Willow Biosciences Inc. Sharpe ratio is -0.71. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Willow Biosciences Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.71
2.26
WLLW.TO (Willow Biosciences Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Willow Biosciences Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-98.80%
-1.74%
WLLW.TO (Willow Biosciences Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Willow Biosciences Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Willow Biosciences Inc. was 99.04%, occurring on Jan 29, 2025. The portfolio has not yet recovered.

The current Willow Biosciences Inc. drawdown is 98.80%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.04%Feb 11, 2021995Jan 29, 2025
-83.86%Jun 5, 2019257Jun 16, 2020164Feb 10, 2021421
-50%Apr 16, 201920May 14, 20194May 21, 201924
-33.33%Feb 1, 20195Feb 8, 20199Feb 27, 201914
-27.27%Dec 24, 20182Dec 27, 201819Jan 31, 201921

Volatility

Volatility Chart

The current Willow Biosciences Inc. volatility is 90.93%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025February
90.93%
3.99%
WLLW.TO (Willow Biosciences Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Willow Biosciences Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Willow Biosciences Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab